Involved in several processes, including positive regulation of axon extension; small GTPase-mediated signal transduction; and substrate-dependent cell migration, cell extension. Predicted to be located in several cellular components, including actin cytoskeleton; cytosol; and nucleoplasm. Predicted to be active in basement membrane and glutamatergic synapse. Human ortholog(s) of this gene implicated in congenital mirror movement disorder. Orthologous to human NTN1 (netrin 1); INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran.
[Tetrachlorodibenzodioxin affects the methylation of NTN1 intron] which results in decreased expression of NTN1 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NTN1 promoter]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NTN1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NTN1 mRNA
[Dactinomycin co-treated with nutlin 3] results in increased expression of NTN1 mRNA and [Dactinomycin co-treated with nutlin 3] results in increased secretion of NTN1 protein
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NTN1 mRNA and Benzo(a)pyrene promotes the reaction [AHR protein binds to NTN1 promoter]
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NTN1 mRNA
[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NTN1 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NTN1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NTN1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NTN1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NTN1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NTN1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NTN1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NTN1 mRNA
[LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of NTN1 mRNA and [Maneb co-treated with Paraquat] results in decreased expression of NTN1 mRNA
[Dactinomycin co-treated with nutlin 3] results in increased expression of NTN1 mRNA and [Dactinomycin co-treated with nutlin 3] results in increased secretion of NTN1 protein
[Air Pollutants results in increased abundance of Ozone] which results in increased expression of NTN1 mRNA and [MBL1 co-treated with MBL2] promotes the reaction [[Air Pollutants results in increased abundance of Ozone] which results in increased expression of NTN1 mRNA]
[LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of NTN1 mRNA and [Maneb co-treated with Paraquat] results in decreased expression of NTN1 mRNA
[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NTN1 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NTN1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NTN1 mRNA